Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DOW INC.DOW · Entity 3233 | Chief Financial Officer | February 12, 2026 | February 17, 2026 |
| HUNTINGTON BANCSHARES INC /MD/HBAN · Entity 3125 | Director | October 01, 2026 | October 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DOW INC.
Report date February 12, 2026 · Filed February 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 118,761 |
Reported balance
After 2026-02-12 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-12 · Grant · Acquired 21,200 · Balance 118,761 F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment. F2: Total includes previously reported restricted stock units. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.65 · Expires 2036-02-12 | Direct | 115,350 |
Reported balance
After 2026-02-12 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-12 · Grant · Acquired 115,350 · Balance 115,350 F3: This option will vest in three equal annual installments beginning on February 12, 2027. Option shares will be used to satisfy withholding taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Restricted stock units to be delivered in one installment on or about February 12, 2029, subject to continued employment.
F2: Total includes previously reported restricted stock units.
F3: This option will vest in three equal annual installments beginning on February 12, 2027. Option shares will be used to satisfy withholding taxes.
HUNTINGTON BANCSHARES INC /MD/
Report date October 01, 2026 · Filed October 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 124,093.114 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Grant · Acquired 632.361 · Balance 124,093.114 |
| Common StockSEC Table I · non-derivative | IndirectDirector Deferred Compensation Plan | 5,256.849 |
Reported balance
After 2026-10-01 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2026-10-01 · Grant · Acquired 54.008 · Balance 5,256.849 F1: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. |
Filing footnotes · ownership attribution and instrument terms
F1: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
LEGGETT & PLATT INC
Report date June 21, 2023 · Filed June 22, 2023
Section 16 reporting ended · disclosed 2023-06-22. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,368.1185 |
Reported balance
After 2023-06-21 transaction · row 1
1 source rowRow 1 · 2023-06-21 · Disposition to issuer · Disposed 14,261 · Balance 70,368.1185 F1: Represents an exempt transaction under Rule 16b-3(e) regarding the forfeiture of unvested restricted stock units by the terms of the award. Separate from this forfeiture, the Reporting Person will receive, pursuant to a Mutual Separation Agreement dated June 21, 2023, a future payment or benefit of $438,811, which amount was indirectly based on the value of such restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an exempt transaction under Rule 16b-3(e) regarding the forfeiture of unvested restricted stock units by the terms of the award. Separate from this forfeiture, the Reporting Person will receive, pursuant to a Mutual Separation Agreement dated June 21, 2023, a future payment or benefit of $438,811, which amount was indirectly based on the value of such restricted stock units.
TCF FINANCIAL CORP
Report date June 09, 2021 · Filed June 09, 2021
Section 16 reporting ended · disclosed 2021-06-09. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2021-06-09 transaction · row 1
1 source rowRow 1 · 2021-06-09 · Disposition to issuer · Disposed 10,066 · Balance 0 F1: Pursuant to the terms of the agreement and plan of merger, dated as of December 13, 2020 (the "Merger Agreement"), between the issuer and Huntington Bancshares Incorporated, a Maryland corporation ("Huntington"), pursuant to which the issuer will merge with and into Huntington (the "Merger"), at the effective time of the Merger (the "Effective Time"), each share of issuer common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) converted into the right to receive 3.0028 shares of Huntington common stock (the "Exchange Ratio"). All fractional share holdings were paid in cash. The Merger closed on June 9, 2021. On June 8, 2021, the closing price of the issuer was $45.18, and the closing price of Huntington was $15.21. |
| Common StockSEC Table I · non-derivative | IndirectDeferred Compensation Plan | 0 |
Reported balance
After 2021-06-09 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2021-06-09 · Disposition to issuer · Disposed 10,411.3876 · Balance 0 F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. F1: Pursuant to the terms of the agreement and plan of merger, dated as of December 13, 2020 (the "Merger Agreement"), between the issuer and Huntington Bancshares Incorporated, a Maryland corporation ("Huntington"), pursuant to which the issuer will merge with and into Huntington (the "Merger"), at the effective time of the Merger (the "Effective Time"), each share of issuer common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) converted into the right to receive 3.0028 shares of Huntington common stock (the "Exchange Ratio"). All fractional share holdings were paid in cash. The Merger closed on June 9, 2021. On June 8, 2021, the closing price of the issuer was $45.18, and the closing price of Huntington was $15.21. F3: The shares noted are derivative securities based on the Reporting Person's benefits under a non-qualified plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the agreement and plan of merger, dated as of December 13, 2020 (the "Merger Agreement"), between the issuer and Huntington Bancshares Incorporated, a Maryland corporation ("Huntington"), pursuant to which the issuer will merge with and into Huntington (the "Merger"), at the effective time of the Merger (the "Effective Time"), each share of issuer common stock issued and outstanding immediately prior to the Effective Time (other than certain excluded shares) converted into the right to receive 3.0028 shares of Huntington common stock (the "Exchange Ratio"). All fractional share holdings were paid in cash. The Merger closed on June 9, 2021. On June 8, 2021, the closing price of the issuer was $45.18, and the closing price of Huntington was $15.21.
F2: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities.
F3: The shares noted are derivative securities based on the Reporting Person's benefits under a non-qualified plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 24, 2020 Filed Apr 27, 2020 17:47 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 45.8563 | $23.90 | $1,096.15 |
DisclosureSEC source: 0001127602-20-014526 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,807.6905 Read SEC document |
| April 24, 2020 Filed Apr 27, 2020 17:47 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 19.3728 | $25.40 | $492.03 |
DisclosureSEC source: 0001127602-20-014526 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,761.8342 Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:44 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 7.1567 | $21.12 | $151.15 |
DisclosureSEC source: 0001127602-20-013866 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,742.4614 Read SEC document |
| April 15, 2020 Filed Apr 16, 2020 20:44 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 15.6378 | $22.44 | $350.91 |
DisclosureSEC source: 0001127602-20-013866 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,735.3047 Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 14:41 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 91.7131 | $23.90 | $2,192.31 |
DisclosureSEC source: 0001127602-20-013551 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,719.6669 Read SEC document |
| April 09, 2020 Filed Apr 10, 2020 14:41 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 40.9524 | $25.40 | $1,040.11 |
DisclosureSEC source: 0001127602-20-013551 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,627.9538 Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 16:51 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 98.0461 | $22.36 | $2,192.31 |
DisclosureSEC source: 0001127602-20-012116 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,587.0014 Read SEC document |
| March 27, 2020 Filed Mar 30, 2020 16:51 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 43.7803 | $23.76 | $1,040.11 |
DisclosureSEC source: 0001127602-20-012116 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,488.9553 Read SEC document |
| March 27, 2020 Filed Mar 31, 2020 16:38 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | GrantCommon Stock | 1,010.946 | $24.73 | $24,999.68 |
DisclosureSEC source: 0000019612-20-000068 · wf-form4_158568709486885.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · Deferred Compensation Plan Disclosed balance after: 1,010.946 F1 · shares: Purchased pursuant to the Reporting Person's deferral of their cash retainer into the Directors Deferred Compensation Plan. F2 · balance_after: The filing of this statement shall not be construed as an admission that the undersigned is, for the purpose of Section 16 of the Securities and Exchange Act of 1934 or otherwise, the beneficial owner of the securities. F3 · ownership.nature: The shares noted are derivative securities based on the Reporting Person's benefits under a non-qualified plan Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 20:07 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 84.4756 | $25.95 | $2,192.31 |
DisclosureSEC source: 0001127602-20-010772 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,445.175 Read SEC document |
| March 13, 2020 Filed Mar 16, 2020 20:07 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 37.7207 | $27.57 | $1,040.11 |
DisclosureSEC source: 0001127602-20-010772 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,360.6994 Read SEC document |
| March 02, 2020 Filed Mar 3, 2020 21:43 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 509.2913 | $34.21 | $17,424.13 |
DisclosureSEC source: 0001127602-20-009047 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,322.9787 Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:57 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 69.097 | $31.73 | $2,192.31 |
DisclosureSEC source: 0001127602-20-008619 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,813.6874 Read SEC document |
| February 28, 2020 Filed Mar 2, 2020 21:57 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 30.8537 | $33.71 | $1,040.11 |
DisclosureSEC source: 0001127602-20-008619 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,744.5904 Read SEC document |
| February 18, 2020 Filed Feb 19, 2020 21:41 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 10,360 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-006442 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,713.7367 F1 · shares: Represents restricted stock units (settled solely in common stock on a one-to-one basis), which vest in one-third increments on the first, second and third anniversaries of the grant date. Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 15:28 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 60.0962 | $36.48 | $2,192.31 |
DisclosureSEC source: 0001127602-20-005890 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,353.7367 Read SEC document |
| February 14, 2020 Filed Feb 18, 2020 15:28 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 26.8346 | $38.76 | $1,040.11 |
DisclosureSEC source: 0001127602-20-005890 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,293.6405 Read SEC document |
| January 31, 2020 Filed Feb 3, 2020 20:50 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 57.5833 | $38.07 | $2,192.31 |
DisclosureSEC source: 0001127602-20-003113 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,266.8059 Read SEC document |
| January 31, 2020 Filed Feb 3, 2020 20:50 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 25.7125 | $40.45 | $1,040.11 |
DisclosureSEC source: 0001127602-20-003113 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,209.2226 Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 16:14 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | Exercise / conversionStock Units · Derivative | 334.047 | $0.00 | $0.00 |
DisclosureSEC source: 0000019612-20-000018 · wf-form4_157981402981053.xml · derivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 334.047 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum upon the termination of the Plan. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F1 · derivative.exercise_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum upon the termination of the Plan. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F1 · derivative.expiration_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum upon the termination of the Plan. The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. Read SEC document |
| January 21, 2020 Filed Jan 23, 2020 16:14 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | Exercise / conversionCommon Stock | 334 | $0.00 | $0.00 |
DisclosureSEC source: 0000019612-20-000018 · wf-form4_157981402981053.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,066 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:44 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 53.5232 | $40.96 | $2,192.31 |
DisclosureSEC source: 0001127602-20-002032 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,183.5101 Read SEC document |
| January 17, 2020 Filed Jan 21, 2020 16:44 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 23.8996 | $43.52 | $1,040.11 |
DisclosureSEC source: 0001127602-20-002032 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,129.9869 Read SEC document |
| January 15, 2020 Filed Jan 16, 2020 19:57 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 1.6134 | $43.34 | $69.93 |
DisclosureSEC source: 0001127602-20-001765 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,106.0873 Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 20:50 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 53.1185 | $39.82 | $2,115.39 |
DisclosureSEC source: 0001127602-20-001102 · form4.xml · nonDerivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,104.4739 Read SEC document |
| January 03, 2020 Filed Jan 6, 2020 20:50 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 23.6724 | $42.31 | $1,001.65 |
DisclosureSEC source: 0001127602-20-001102 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,051.3554 Read SEC document |
| December 20, 2019 Filed Dec 20, 2019 23:17 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 22.8621 | $43.76 | $1,000.40 |
DisclosureSEC source: 0001127602-19-035695 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,027.683 Read SEC document |
| December 16, 2019 Filed Dec 18, 2019 16:17 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | GrantStock Units · Derivative | 334.047 | $45.76 | $15,285.99 |
DisclosureSEC source: 0000019612-19-000238 · wf-form4_157670386140507.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 334.047 Underlying: Common Stock · 334.047 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing a cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing a cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing a cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| December 06, 2019 Filed Dec 9, 2019 20:46 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 22.1771 | $45.11 | $1,000.40 |
DisclosureSEC source: 0001127602-19-034542 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,004.8209 Read SEC document |
| November 22, 2019 Filed Nov 25, 2019 18:24 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 22.4908 | $44.48 | $1,000.40 |
DisclosureSEC source: 0001127602-19-033649 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,982.6438 Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 15:50 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 21.3291 | $46.90 | $1,000.40 |
DisclosureSEC source: 0001127602-19-032443 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,960.153 Read SEC document |
| October 25, 2019 Filed Oct 28, 2019 18:13 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 26.0097 | $38.46 | $1,000.40 |
DisclosureSEC source: 0001127602-19-031141 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,938.8239 Read SEC document |
| October 15, 2019 Filed Oct 16, 2019 20:43 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 0.2798 | $35.72 | $9.99 |
DisclosureSEC source: 0001127602-19-030646 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,912.8142 Read SEC document |
| October 11, 2019 Filed Oct 15, 2019 16:02 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 28.7901 | $34.75 | $1,000.40 |
DisclosureSEC source: 0001127602-19-030481 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,912.5344 Read SEC document |
| September 27, 2019 Filed Sep 30, 2019 20:08 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 28.762 | $34.78 | $1,000.40 |
DisclosureSEC source: 0001127602-19-029243 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,883.7443 Read SEC document |
| September 13, 2019 Filed Sep 16, 2019 19:26 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 24.9823 | $35.81 | $894.63 |
DisclosureSEC source: 0001127602-19-028429 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,854.9823 Read SEC document |
| September 03, 2019 Filed Sep 4, 2019 18:59 UTC | LEGGETT & PLATT INC LEG · Entity 9532 | GrantCommon Stock | 12,830 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-19-027837 · form4.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Executive Vice President - CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,830 Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 11:50 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | Exercise / conversionStock Units · Derivative | 9,732.11 | $0.00 | $0.00 |
DisclosureSEC source: 0000019612-19-000199 · wf-form4_156597063507679.xml · derivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,732.11 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of TCF Financial Corporation, a Delaware corporation, with and into TCF Financial Corporation, a Michigan corporation (formerly known as Chemical Financial Corporation). The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F1 · derivative.exercise_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of TCF Financial Corporation, a Delaware corporation, with and into TCF Financial Corporation, a Michigan corporation (formerly known as Chemical Financial Corporation). The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. F1 · derivative.expiration_date: Stock units issued under the Chemical Financial Corporation Directors' Deferred Stock Plan were converted into shares of common stock on a one-for-one basis in a lump sum in connection with the merger of TCF Financial Corporation, a Delaware corporation, with and into TCF Financial Corporation, a Michigan corporation (formerly known as Chemical Financial Corporation). The reporting person will receive cash in lieu of any fractional shares that would otherwise have resulted from such conversion. Read SEC document |
| August 14, 2019 Filed Aug 16, 2019 11:50 UTC | TCF FINANCIAL CORP TCF · Entity 106138 | Exercise / conversionCommon Stock | 9,732 | $0.00 | $0.00 |
DisclosureSEC source: 0000019612-19-000199 · wf-form4_156597063507679.xml · nonDerivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 17:05 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 83.159 | $39.45 | $3,280.62 |
DisclosureSEC source: 0000019612-19-000144 · wf-form4_156141032457783.xml · derivative · entry 2 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,732.11 Underlying: Common Stock · 83.159 shares Expires not disclosed F2 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F2 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F2 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| June 21, 2019 Filed Jun 24, 2019 17:05 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 4,139.747 | $39.45 | $163,313.02 |
DisclosureSEC source: 0000019612-19-000144 · wf-form4_156141032457783.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,648.951 Underlying: Common Stock · 4,139.747 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| March 15, 2019 Filed Mar 18, 2019 16:31 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 42.34 | $43.90 | $1,858.73 |
DisclosureSEC source: 0000019612-19-000079 · wf-form4_155294109466958.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,509.204 Underlying: Common Stock · 42.34 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| December 21, 2018 Filed Dec 26, 2018 08:35 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 51.346 | $35.86 | $1,841.27 |
DisclosureSEC source: 0000019612-18-000169 · wf-form4_154583134146998.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,466.864 Underlying: Common Stock · 51.346 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| September 21, 2018 Filed Sep 25, 2018 08:35 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 32.331 | $56.61 | $1,830.26 |
DisclosureSEC source: 0000019612-18-000145 · wf-form4_153787893096451.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,415.518 Underlying: Common Stock · 32.331 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| June 15, 2018 Filed Jun 18, 2018 15:47 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 25.819 | $58.10 | $1,500.08 |
DisclosureSEC source: 0000019612-18-000103 · wf-form4_152935125463372.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,383.187 Underlying: Common Stock · 25.819 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| May 31, 2018 Filed Jun 4, 2018 12:56 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 2,910.064 | $56.12 | $163,312.79 |
DisclosureSEC source: 0000019612-18-000088 · wf-form4_152813134915960.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,357.368 Underlying: Common Stock · 2,910.064 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing an equity retainer and any cash retainer voluntarily deferred pursuant to the Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| March 16, 2018 Filed Mar 19, 2018 17:03 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 11.706 | $58.26 | $681.99 |
DisclosureSEC source: 0000019612-18-000061 · wf-form4_152149341343140.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,447.304 Underlying: Common Stock · 11.706 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| December 15, 2017 Filed Dec 19, 2017 15:10 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 12.255 | $55.37 | $678.56 |
DisclosureSEC source: 0000019612-17-000105 · wf-form4_151371421463119.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,435.598 Underlying: Common Stock · 12.255 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| September 15, 2017 Filed Sep 19, 2017 14:26 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 13.879 | $48.61 | $674.66 |
DisclosureSEC source: 0000905729-17-000269 · tate4_091917.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,423.343 Underlying: Common Stock · 13.879 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
| June 16, 2017 Filed Jun 20, 2017 10:52 UTC | TCF FINANCIAL CORP CHFC · Entity 106138 | GrantStock Units · Derivative | 13.298 | $48.65 | $646.95 |
DisclosureSEC source: 0000905729-17-000225 · tate4_062017.xml · derivative · entry 1 Tate Jeffrey L. · CIK 0001699485 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,409.464 Underlying: Common Stock · 13.298 shares Expires not disclosed F1 · derivative.exercise_price: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.exercise_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. F1 · derivative.expiration_date: Award of stock units representing dividend equivalents pursuant to Chemical Financial Corporation Directors' Deferred Stock Plan. Shares of common stock are issuable on a one-for-one basis in either a lump sum or installments after termination of service as a director or upon a change in control of the Company. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.